Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Julphar
UBS
US Army
Queensland Health
Merck

Generated: June 24, 2019

DrugPatentWatch Database Preview

Claims for Patent: 10,016,407

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,016,407
Title:Pharmaceutical compositions and methods of using the same
Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
Inventor(s): Moshal; Jeffrey M. (Allentown, PA), Libman; Michael (Allentown, PA)
Assignee: GENUS LIFESCIENCES INC. (Allentown, PA)
Application Number:15/849,575
Patent Claims: 1. A method of administering a local anesthetic prior to performing a diagnostic or surgical procedure on a subject with hepatic or renal impairment comprising: soaking one or more pledgets in about 4 mL of a ready-to-use composition comprising: about 3.6% to about 4.4% cocaine hydrochloride; about 0.07% to about 0.20% sodium benzoate; an acidulant; optionally, at least one coloring additive; and water, contacting each pledget on a nasal mucous membrane of the subject for up to 20 minutes, and removing each pledget.

2. The method of claim 1, wherein the subject has hepatic impairment.

3. The method of claim 2, wherein the hepatic impairment leads to increased systemic exposure of the cocaine hydrochloride.

4. The method of claim 2, wherein the subject has a Child-Pugh Grade of Grade B.

5. The method of claim 2, wherein the subject has a Child-Pugh Grade of Grade C.

6. The method of claim 1, wherein the subject has renal impairment.

7. The method of claim 6, wherein the renal impairment leads to increased systemic exposure of the cocaine hydrochloride.

8. The method of claim 6, wherein the renally impaired subject has an estimated glomerular filtration rate (eGFR) of about 15 mL/min/1.73 m.sup.2 to about 29 mL/min/1.73 m.sup.2.

9. The method of claim 1, wherein, the procedure is a nasal endoscopy.

10. The method of claim 1, wherein the acidulant is citric acid.

11. A method of administering a local anesthetic prior to performing a diagnostic or surgical procedure on a subject with hepatic or renal impairment comprising: soaking one or more pledgets in about 4 mL of a ready-to-use composition comprising: about 3.6% to about 4.4% cocaine hydrochloride; a preservative; about 0.01% to about 1.0% citric acid; optionally, at least one coloring additive; and water, contacting each pledget on a nasal mucous membrane of the subject for up to 20 minutes, and removing each pledget.

12. The method of claim 11, wherein the subject has hepatic impairment.

13. The method of claim 11, wherein the hepatic impairment leads to increased systemic exposure of the cocaine hydrochloride.

14. The method of claim 12, wherein the subject has a Child-Pugh Grade of Grade B.

15. The method of claim 12, wherein the subject has a Child-Pugh Grade of Grade C.

16. The method of claim 11, wherein the subject has renal impairment.

17. The method of claim 11, wherein the renal impairment leads to increased systemic exposure of the cocaine hydrochloride.

18. The method of claim 16, wherein, the renally impaired subject has an estimated glomerular filtration rate (eGFR) of about 15 mL/min/1.73 m.sup.2 to about 29 mL/min/1.73 m.sup.2.

19. The method of claim 11, wherein, the procedure is a nasal endoscopy.

20. The method of claim 11, wherein the preservative is sodium benzoate.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
McKinsey
Daiichi Sankyo
Baxter
Cantor Fitzgerald
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.